Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells

Amandda Évelin Silva-Carvalho1, Marlon Henrique Cardoso2, Thuany Alencar-Silva3

  • 1Laboratório de Hematologia e Células-Tronco, Departamento de Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brazil.

Insights

Mesenchymal Stem Cells (MSCs) produce antimicrobial peptides (AMPs) that fight infections and modulate MSC functions. This review explores their therapeutic potential in various clinical situations.

Area of Science:

  • Stem cell biology
  • Immunology
  • Antimicrobial research

Background:

  • Mesenchymal Stem Cells (MSCs) possess immunomodulatory and antimicrobial properties.
  • MSCs secrete antimicrobial peptides (AMPs) like hepcidin, cathelicidin LL-37, and β-defensin-2.
  • These AMPs target a broad spectrum of pathogens, including bacteria, fungi, yeasts, and viruses.

Purpose of the Study:

  • To review the production of AMPs by MSCs.
  • To revise the diverse functions of MSC-derived AMPs, including their impact on MSCs.
  • To present an overview of clinical applications for MSC antimicrobial properties.

Main Methods:

  • Literature review of studies on MSCs and AMPs.
  • Analysis of AMP production mechanisms by MSCs.
  • Evaluation of existing and potential therapeutic strategies.

Main Results:

  • MSCs are a source of potent AMPs with broad-spectrum antimicrobial activity.
  • AMPs produced by MSCs also influence MSC proliferation, migration, and regeneration.
  • Clinical applications for MSC-based antimicrobial therapies are being explored.

Conclusions:

  • MSC-derived AMPs offer a promising avenue for combating infections.
  • Understanding the dual role of AMPs in pathogen defense and MSC modulation is crucial.
  • Combining MSCs and AMPs may lead to enhanced therapeutic strategies for infectious diseases.